Rheumatoid arthritis: the role of reactive oxygen species in disease development and therapeutic strategies

Kyra A Gelderman, Malin Hultqvist, Lina M Olsson, Kristin Bauer, Angela Pizzolla, Peter Olofsson, Rikard Holmdahl

Research output: Contribution to journalArticleResearchpeer-review

94 Citations (Scopus)

Abstract

Autoimmune diseases such as rheumatoid arthritis (RA) are chronic diseases that cannot be prevented or cured. If the pathologic basis of such diseases would be known, it might be easier to develop new drugs interfering with critical pathways. Genetic analysis of animal models for autoimmune diseases can result in discovery of proteins and pathways that play a key function in pathogenesis, which may provide rationales for new therapeutic strategies. Currently, only the MHC class II is clearly associated with human RA and animal models for RA. However, recent data from rats and mice with a polymorphism in Ncf1, a member of the NADPH oxidase complex, indicate a role for oxidative burst in protection from arthritis. Oxidative burst-activating substances can treat and prevent arthritis in rats, as efficiently as clinically applied drugs, suggesting a novel pathway to a therapeutic target in human RA. Here, the authors discuss the role of oxygen radicals in regulating the immune system and autoimmune disease. It is proposed that reactive oxygen species set the threshold for T cell activation and thereby regulate chronic autoimmune inflammatory diseases like RA. In the light of this new hypothesis, new possibilities for preventive and therapeutic treatment of chronic inflammatory diseases are discussed. A? Mary Ann Liebert, Inc.
Original languageEnglish
Pages (from-to)1541 - 1567
Number of pages27
JournalAntioxidants and Redox Signaling
Volume9
Issue number10
DOIs
Publication statusPublished - 2007
Externally publishedYes

Cite this